Catalent
CTLT
#1813
Rank
ยฃ8.41 B
Marketcap
ยฃ46.39
Share price
0.00%
Change (1 day)
2.20%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -ยฃ5.08

According to Catalent's latest financial reports the company's current EPS (TTM) is -ยฃ4.63. In 2023 the company made an earnings per share (EPS) of -ยฃ4.97 a decrease over its 2022 EPS that were of ยฃ1.66.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-ยฃ5.082.3%
2023-ยฃ4.97-399.56%
2022ยฃ1.66-30.58%
2021ยฃ2.3979.67%
2020ยฃ1.33114.12%
2019ยฃ0.62-15%
2018ยฃ0.7375.44%
2017ยฃ0.42-22.97%
2016ยฃ0.54-59.56%
2015ยฃ1.34282.05%
2014ยฃ0.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-ยฃ0.24-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
-ยฃ4.36-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-ยฃ0.55-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-ยฃ1.08-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA